本季度信息
截至2025年12月31日止六个月，百本医护录得营收约34,900,000港元，同比下降11.6%。同期，经调整净利润（对应公告所列“本公司权益持有人应占溢利”）为9,300,000港元，同比减少7.9%。经营溢利由去年同期的13,821,000港元降至11,176,000港元，经营活动产生的现金净额则为约6,921,000港元。
成本端方面，员工福利开支从14,329,000港元增至15,348,000港元，其他经营开支由5,490,000港元增长至6,090,000港元。
业务分项
主力业务“医护人手解决方案服务”在报告期内实现营收约26,475,000港元，较上年同期的32,573,000港元下滑18.7%。外展个案评估与疫苗接种服务收入约3,631,000港元，销售商品1,740,000港元，诊所服务3,096,000港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.